Kwarlay.com

Navigating the News Maze with Clarity

    • Medicine

    AD04-13 Study Highlights Consistent Bioavailability and Safety for Alcohol Use Disorder Treatment

    admin Posted on

    Cary Claiborne, CEO, Adial Pharmaceuticals, discusses promising results of the AD04-13 study in patients with Alcohol Use Disorder

    LEAVE A RESPONSE

    Your email address will not be published. Required fields are marked *

    admin
    View all posts

    You Might Also Like

    Slot
    TOGEL ONLINE